Biotech stocks are ready to break out. They just need one more thing

[ad_1] While debate rages on about when the Federal Reserve might start cutting interest rates, biotech industry analysts are making the case that the argument for stocks in the sector … Read More

‘This is the mental health moment’: Innovation and M&A are helping to boost these stocks to new heights

[ad_1] There’s been a lot of chatter about the mental health crisis since the Covid-19 pandemic. Overall, 12 mental health disorders affect 970 million people around the world — or … Read More

Federal judge tosses lobbying group’s lawsuit challenging Medicare drug price negotiations

[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna … Read More

Senators grill Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

[ad_1] Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey on issuing subpoenas for pharmaceutical company CEOs to testify regarding drug prices, in the Capitol, Jan. … Read More

Fourth-quarter earnings are shaping up to be the best of 2023, but there’s a catch

[ad_1] Traders work on the floor at the New York Stock Exchange on Feb. 1, 2024. Brendan McDermid | Reuters Here’s how big of a surprise corporate profits have been … Read More

Bristol Myers Squibb results top estimates as new drugs post strong sales growth 

[ad_1] Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio of new drugs posted strong sales growth.  Here’s what the company reported for … Read More

Here are Jim Cramer’s rapid-fire takeaways on 6 stocks in the news Friday

[ad_1] Clorox – The consumer products giant saw a huge earnings beat. It’s also rebounding from last year’s cyberattack. “Things are back online, and there’s tremendous demand for their product,” … Read More